The COVID-19 vaccine is our best defence against the virus used alongside effective social distancing, wearing a mask and washing your hands.
Getting vaccinated means protecting yourself and may also help to protect your family, friends and patients from the virus.
The vaccine has been developed and approved following a number of clinical trials involving thousands of people across the world. It has also undergone mandatory safety tests to ensure it is safe for humans.
It is given in two doses by your local NHS service. Appointments will be held up to 12 weeks apart, based on updated guidance from the UK’s Chief Medical Officers.
Vaccine safety and effectiveness
Yes. As with any medicine, vaccines are highly-regulated products. There are checks at every stage in the development and manufacturing process, and continued monitoring once it has been authorised and is being used in the wider population.
The NHS does not offer any COVID-19 vaccinations to the public unless it is approved as safe and effective by the UK regulator. The Medicines and Healthcare products Regulatory Agency (MHRA), the official UK regulator authorising licensed use of medicines and vaccines by healthcare professionals, make this decision for each potential vaccine, and we have full confidence in their expert judgement and processes.
Over 200,000 AstraZeneca (AZ) COVID vaccines have now been safely administered to people in Birmingham and Solihull.
More than 11 million doses of the AZ COVID vaccine have also been administered across the UK and it is proven to be safe and effective against COVID-19.
While blood clots can occur naturally and are not uncommon, reports of blood clots to the Medicines and Healthcare Regulatory Agency (MHRA) are not greater than the number that would have occurred naturally in the vaccinated population. It is therefore reassuring that there is currently no evidence of an increase in blood clots in the UK.
The safety of the public will always come first, therefore we urge the people of Birmingham and Solihull to get their COVID-19 vaccine when asked to do so, to protect themselves, the people around them, and their loved ones.
Dr Phil Bryan, MHRA Vaccines Safety Lead said: “Vaccine safety is of paramount importance and we continually monitor the safety of vaccines to ensure that the benefits outweigh any potential risks.
“It has not been confirmed that the report of a blood clot, in Denmark, was caused by the COVID-19 Vaccine AstraZeneca.
“The Danish, Norwegian and and Icelandic authorities’ action to temporarily suspend use of the vaccine is precautionary whilst they investigate.
“Blood clots can occur naturally and are not uncommon. More than 11 million doses of the COVID-19 Vaccine AstraZeneca vaccine have now been administered across the UK.
“Reports of blood clots received so far are not greater than the number that would have occurred naturally in the vaccinated population.
“The safety of the public will always come first. We are keeping this issue under close review but available evidence does not confirm that the vaccine is the cause.
“People should still go and get their COVID-19 vaccine when asked to do so.”
The International Society on Thrombosis and Haemostasis (ISTH), the leading international body on thrombosis recommends: “all eligible adults continue to receive their COVID-19 vaccinations, despite the recent decisions by Denmark, Norway and Iceland to at least temporarily suspend the use of the AstraZeneca vaccine due to reports of thrombosis.
“At this time, the small number of reported thrombotic events relative to the millions of administered COVID-19 vaccinations does not suggest a direct link. Thrombotic events are common in the general population and have not previously been associated with vaccination. At present, we do not know whether the timing of the blood clots with vaccination is coincidental or whether vaccination may in rare cases increase the risk of thrombosis. Importantly, well-conducted clinical trials of COVID-19 vaccinations did not identify an increased risk of thrombosis.”
If you do have any concerns before or after having a COVID vaccination, please speak to your doctor or health professional. We also encourage everyone to report any suspicion or concern they have beyond the known, mild side effects of the COVID vaccination on the Coronavirus Yellow Card website. Reporters do not need to be sure of a link between a vaccine and a suspected side effect but are still encouraged to report.
You can also read the full response by the MHRA at the link below.
Coronavirus Yellow Card Website: https://coronavirus-yellowcard.mhra.gov.uk
These are important details which the MHRA always consider when assessing candidate vaccines for use.
For these vaccines, like lots of others, they have identified that some people might feel slightly unwell, but they report that no significant side effects have been observed in the tens of thousands of people involved in trials.
All patients will be provided with information on the vaccine they have received, how to look out for any side effects, and what to do if they do occur, including reporting them to the MHRA.
More information on possible side effects can be found at https://www.nhs.uk/conditions/coronavirus-covid-19/coronavirus-vaccination/coronavirus-vaccine/
COVID-19 remains a new infection and close observation by experts continues. At this stage it is unclear whether the vaccine will need to given yearly, like the flu vaccine, or less frequently.
Trials for length of vaccine protection continue and will also inform how vaccination for COVID-19 is recommended in the future.
A good level of protection will be provided by the vaccine two to three weeks after your appointment. It is vital that you continue to adhere to social distancing, mask guidelines and practice good hand hygiene. No vaccine is 100% effective so it is also important you to continue to follow any government or workplace advice even after you have had both doses of the vaccine.
The vaccine is given by injection into the arm or shoulder.
You will need two doses of the vaccine to gain the maximum protection. These doses will be given three to twelve weeks apart. One dose of the vaccine offers important protection, at least in the short term. Updated guidance from the JCVI has recommended that as many people on the JCVI priority list should be offered a first vaccine dose as the initial priority. You will need to attend two appointments to receive both doses. If you do not have both doses the vaccine will not be fully effective.
No. The vaccines are designed to produce an immune response to just a small part of the virus, the spike protein. This is the part of the virus that allows it to enter into human cells and cause infection. No whole COVID-19 virus or live virus is used in the vaccines. This means the vaccine cannot give you COVID-19 and does not make you infectious after you have had the vaccine. This means it is also safe for people with a suppressed immune system.
Yes. The MHRA has advised that pregnant women can have the vaccine, however recommend they discuss this with their clinical team first. Those who are breast feeding may have the vaccine also.
While there are myths on social media that the vaccine can effect fertility, there is no scientific evidence to suggest that the vaccine affects fertility or the ability to carry a child to full term.
During the Pfizer-BioNTech vaccine study, there were 23 study participants who became pregnant during their vaccine trial. There was one pregnancy loss, but this was in a participant who received the placebo, not the vaccine.
There are no known risks associated with giving non-“live” vaccines in relation to fertility.
In contrast to the vaccine, there is some evidence to suggest that being infected with COVID-19 can lead to orchitis, or inflammation of the testicles. This has also been seen with other viruses such as mumps, hepatitis and Epstein-Barr Virus (EBV).
Pregnant women who are frontline health or social care workers, including carers in a residential home, can discuss the option of vaccination with their clinical team. This is because the risk of exposure to COVID-19 may be higher, even if they have a lower risk of experiencing complications if they are otherwise well.
The JCVI also now advises that there is no known risk in giving these vaccines to breastfeeding women.
No. You should have your flu jab either a minimum of 7 days before the first COVID-19 vaccination dose or 7 days after you have had the second dose.
No. You are not required to have a test prior to your vaccination, however if you have any symptoms of COVID-19 infection you must follow government guidelines and must not attend the appointment. You should follow advice you have been given to re-book your appointment.
You should not have the vaccine if you have had confirmed COVID-19 infection in the previous 28 days unless you are advised by your doctor that it is suitable for you to do so.
There are no animal products listed in the ingredients.
A detailed review of the vaccines and their ingredients have been provided by the MHRA and can be found at the following links:
For the Pfizer/BioNTech vaccine information is available here: https://www.gov.uk/government/publications/regulatory-approval-of-pfizer-biontech-vaccine-for-covid-19
For the Oxford/AstraZeneca vaccine information is available here: https://www.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca
The British Islamic Medical Association have produced a helpful guide for the Muslim community which can be found at https://britishima.org/pfizer-biontech-covid19-vaccine/
Not at this time.
Yes, if they are in a priority group identified by the Joint Committee on Vaccination and Immunisation (JCVI). We don’t yet know how long immunity lasts after having been infected with COVID-19, so getting vaccinated is just as important for those who have already had it as it is for those who haven’t.
Yes; it is unclear how long antibodies produced following infection may provide protection and whether the protection is as effective as that provided by vaccination. It is therefore recommended you have a vaccine if offered one.
No. Vaccine gives will be based on availability, except for when a patient’s medical history means a specific vaccine must be used. Any vaccines that are available will have been approved by the medicine regulatory authorities so you should be assured that whatever vaccine you are offered, it is safe and effective.
We will need to see the final clinical evidence from trials on this. The important point for any vaccine is whether MHRA approve it for use – if it does then that means it’s a worthwhile vaccine to have and people should have it if they are eligible. The Government has in principle secured access to six different vaccine candidates, including the now approved BioNTech/Pfizer and Oxford/AstraZeneca vaccines. The results seen for all the vaccine candidates so far have been very encouraging and if borne out by final assessments would each be classed as being very effective.
No. While the vaccination prevents the development of the infection in around 90-95% of people, there is still a chance of contracting the virus or transmission to others. It is therefore very important to continue wearing a mask, social distancing and practicing good hand hygiene.
These vaccines are safe and effective for the vast majority of people – they have been tested on tens of thousands of people and assessed by experts.
Any person with a history of immediate-onset anaphylaxis or a known allergy to any of the ingredients contained in the vaccines should not receive them. A second dose of the Pfizer/BioNTech vaccine should not be given to those who have experienced anaphylaxis to the first dose of Pfizer/BioNTech vaccination.
Everybody will be screened for potential allergic reactions before getting vaccinated. All vaccinators will have the training they need to deal with any rare cases of adverse reactions, and all venues will be equipped to care for people who need it – just like with any other vaccine.
Since the vaccination programme began in early December, the MHRA has been notified of two reports of anaphylaxis, and a further possible allergic reaction, shortly after receiving the Pfizer/BioNTech COVID-19 vaccine. The individuals received prompt treatment and recovered.
Incidents such as these are common with new vaccines and the MHRA has tried and tested processes to deal with them. The public can be reassured that we continue to adhere to the highest standards of safety as we provide this life-saving vaccine to those who need it most. Individuals should not get the vaccine if they have had a severe allergic reaction to any of the vaccine ingredients.
The Government has secured access to six different vaccine candidates, across four different vaccine types, totalling over 350 million doses. This includes:
- BioNTech/Pfizer BioNTech alliance – phase 3 clinical trials (40m doses)
- University of Oxford/AstraZeneca partnership – phase 3 clinical trials (100m doses)
- Moderna (7m doses)
Now the Pfizer BionTech and Oxford Astrazeneca have both been approved, enough doses will be available for everyone who wants one. However, we won’t have all of these doses immediately. The speed of vaccination will be subject to supply – but the UK expects to have received tens of millions of doses of vaccine by Easter. This is going to be a long-term programme.
Over the coming weeks and as more supplies are available, vaccination appointments will continue to be rolled out to priority groups as per the JCVI’s guidance.
Not at this stage unless they fall into one of the priority groups. The priority groups are reviewed by the Joint Committee on Vaccines and Immunisations (JCVI) and, if it is deemed necessary, other groups may also be invited for a vaccination.
The NHS is currently in the process of offering the vaccine to people in the first four priority groups. This includes everyone aged 70 and over, those who live or work in care home, the clinically extremely vulnerable and frontline health and social care staff. When everyone in these groups has had the chance to get their first dose of the vaccine the programme will expand to other priority groups in line with the advice from the Joint Committee on Vaccinations and Immunisations.
Read the latest JCVI advice on priority groups for the COVID-19 vaccination on the GOV.UK website
Yes. Eligible individuals will receive letters in the post sent via the national booking system, inviting them to book an appointment at a mass vaccination centre. They may also be invited to have their vaccination at a local hospital or GP practice. In some cases, people may receive two separate letters, as the national letter may have been printed and sent before the national system has been updated. Eligible individuals can choose where to be vaccinated. This will also be explained in letters they receive.
People classed as clinically extremely vulnerable should have already been contacted by the NHS. If you have not been contacted and think you should have been, please speak to your GP or hospital care team. People defined as clinically extremely vulnerable are listed on the NHS website.
As one of the top four priority groups, clinically extremely vulnerable people should be contacted for their first vaccine appointment in the coming weeks, with all clinically vulnerable people expected to have been offered a vaccine by February 15.
If you provide unpaid care or live with someone eligible to receive a vaccine, you are now eligible to receive the vaccine. All eligible people will be contacted. If you have not been contacted, please be patient as the vaccine rollout continues. If you are unsure if you are classed as a carer, please check using this link: https://forwardcarers.org.uk/info-advice/are-you-a-carer
You can also register as a carer online at https://forwardcarers.org.uk/local-services/carer-register-form. Registering will automatically ensure that your carer status and eligibility for the vaccine is shared with the vaccination programme team. If you are having trouble registering, please call the Birmingham Carer Hub Information and Advice line on 0333 006 9711.
Vaccinating healthcare staff
All front line healthcare staff are being offered the vaccine, with booking details shared with all staff. If you are a health or social care worker and cannot receive the vaccine at your place of work, alternative options will be offered.
There are no plans for a COVID-19 vaccine to be compulsory. Just as with the winter flu vaccine, local NHS employers will be working hard to ensure 100% of staff are able to get vaccinated, and that any concerns that staff have are answered. We are confident that the vast majority of our staff – as they do every year for the flu vaccine – will choose to protect themselves and their patients by getting the vaccine.
This group are a high priority and every effort is being made to vaccinate them quickly and safely. This may be in the Hospital Hubs at their work place for staff, or in the care homes themselves for residents.
When it is the right time people will receive an invitation to come forward. For most people this will be in the form of a letter either from their GP or the national booking system; this will include all the information they need to book their appointments, including their NHS number.
We know lots of people will be eager to get protected but we are asking people not to contact the NHS to get an appointment until they get their letter.
The JCVI set criteria on an ongoing basis for who should get the vaccine when. GPs will be able to call in or go out to patients based on this, using their patient records. A national invite and recall system, drawn from GP patient records, may also be used.
A list of currently open sites is available elsewhere on this site.
If you have had your first jab already through a hospital or GP services, the local NHS will contact you about getting your second.
If you have received a letter from the national booking service and you have already had your first dose of the vaccination, please ignore the letter. This service will require you to book appointments for both doses of the vaccination at the same time.
If you already have a vaccination booked through your GP, please ignore the letter. There is nothing more you need to do.
If you have received a letter from the national booking centre inviting you to book your Covid-19 vaccination you can do this online or on the phone using the details on the first page of the letter. You will need your name, date of birth and NHS number to book. Your letter will state your NHS number in the top right corner. At the time of booking you will be asked to book your first vaccination and your follow up vaccination, which will be around 12 weeks later.
Letters sent by the national booking team are different to letters your GP may also send. If you are trying to book into a mass vaccination centre, please do not contact your GP surgery, as they will be unable to book you into the mass centre. Please use the details in the letter to book your appointment directly, either online or by phone.
The NHS is inviting eligible people as supplies of the vaccine allow. If you have received a letter and live with someone who is also eligible but has not been contacted, it is likely that they will be contacted shortly after. You can wait and book at the same time if you would like to.
People who are housebound will be contacted by their local NHS community vaccination team, based upon lists provided by their local GPs, with details of how they can be vaccinated. This will include home visits.
If your appointment is at a mass vaccination site, please call 119 if you need to reschedule or change your appointment.
For appointments at GP practices please use the contact details provided on your appointment notification.
If you receive a letter in the post through the national booking system, your NHS number will be in the top right corner of the letter. You can also find out your NHS number on the NHS England website:
You will need to enter your name, date of birth and postcode.
If you are 70 or over or on the Shielded Patient List, then you it is likely that you have been contacted by the NHS already.. If you haven’t, this could be for a number of reasons, but is most likely to be because you are not registered with a GP or have recently moved, and we therefore don’t have your contact details.
If you have never registered with a GP or haven’t been to a GP for a number of years, we would recommend speaking with your local practice about registering.
As well as getting access to Covid-19 vaccines, being registered with a GP also means you are invited to important health checks such as for cancer or heart disease, and can access care easier when you need it.
More information on registering with a GP is available at https://www.nhs.uk/nhs-services/gps/how-to-register-with-a-gp-surgery/
If you need to rearrange an appointment that you booked through the NHS website, you can do this through the ‘manage your appointments’ section on the booking page.
If you booked through 119, you can also ring to rearrange your appointment.
If you can’t attend your appointment for any reason, please cancel or rearrange it so that the appointment slot can be given to someone else who needs it.
Yes. Only those who have had a vaccination recorded are marked on our system and are therefore unable to book again.
Roll-out plan in Birmingham and Solihull
This will depend on the number of doses we get, but the NHS aims to vaccinate as many people as safely and quickly as possible.
The NHS has begun vaccinating the priority cohorts. When we get more vaccine supplies this will potentially allow us to go further and faster, but we are not there yet.
The NHS has been working together with local partners to ensure that people are not disadvantaged because of where they live, whether they own a car or if they are not able to get out and about. This is why the NHS has developed three different models of delivery.
NHS Trusts will provide Hospital Hubs where vaccines can be safely stored and those in the highest priority groups can be vaccinated.
Vaccination Centres are also now open, providing vaccination on a large scale. These sites are in well-connected public venues.
GPs and Pharmacies are also providing vaccination services locally in the community.
All vaccine sites in Birmingham and Solihull are receiving regular deliveries of COVID vaccines. Eligible patients are being contacted to book an appointment. Supply is expected to increase over the coming weeks.
If you have your vaccination at a GP surgery, it will be given by the doctor or the practice nurse.
At Vaccination Centres, the vaccine will be given by specially trained staff – either existing staff or those recruited specifically for the programme. There are a number of roles within the vaccination programme and these will require different levels of qualifications and experience.
Public Health England have compiled comprehensive training including injection administration, training on vaccines in general and the specific ones that will be used, and all the mandatory training NHS have to do. Locally, vaccinators will have inductions and orientation and importantly new vaccinators will be supervised and assessed by senior clinicians to ensure both their safety and of course the safety of the people they are vaccinating – just like any other vaccinator.
Our planning will ensure that there is as little as possible impact on other vital services by drawing on a pool of experienced NHS professionals through the NHS Bring Back Scheme, recruiting new vaccinators from amongst a wider group of healthcare professionals and others who complete training, and using independent Occupational Health providers.
Other website information
National booking system
Dr Van-Tam Briefing on COVID-19 Vaccine
Public Health England – Green Book (published 27/11/20)
This chapter includes information on:
- the coronavirus (COVID-19) vaccines.
- the dosage and schedule for the UK.
- recommendations for the use of the vaccine.
British Islamic Medical Association (updated Jan 5 2021)
Answering the myths – COVID-19 myth buster
Top 10 questions Imams and Scholars get asked about vaccines
Information for people with learning disabilities and autism
How to find out your NHS number
British Fertility Association and Association of Reproductive and Clinical Scientists fertility guide
COVID-19 Vaccination Q&A, answering questions on vaccination and fertility
On Wednesday 24 March at 2pm, experts from NHS England & NHS Improvement (Midlands) and Birmingham Women’s Hospital spoke about the Covid vaccination and how it affects men and women who are trying for a family or who are pregnant. Watch the recording.
COVID-19 Vaccinations public meetings
In February, public meetings were held featuring GP and public health leaders in Birmingham and Solihull. You can watch the recordings now:
- COVID-19 Guide for older adults
- COVID-19 Guide for social care workers
- COVID-19 What to expect leaflet
- COVID-19 Why do I have to wait leaflet
- COVID-19 Guide on pregnancy and vaccination
- COVID-19 Guide for older adults Albanian
- COVID-19 Guide for older adults Arabic
- COVID-19 Guide for older adults Bengali
- COVID-19 Guide for older adults Chinese
- COVID-19 Guide for older adults Farsi
- COVID-19 Guide for older adults Gujarati
- COVID-19 Guide for older adults Hindi
- COVID-19 Guide for older adults Nepali
- COVID-19 Guide for older adults Polish
- COVID-19 Guide for older adults Punjabi
- COVID-19 Guide for older adults Romanian
- COVID-19 Guide for older adults Somali
- COVID-19 Guide for older adults Spanish
- COVID-19 Guide for older adults Tagalog
- COVID-19 Guide for older adults Turkish
- COVID-19 Guide for older adults Urdu
- COVID-19 Guide to Phase 2